Accordingly, plasma cystatin C levels are unlikely to be directly correlated with motor neuron degeneration in ALS, though elevated levels may correlate to peripheral metabolic or inflammatory abnormalities during ALS. This evidence concerns the gene CST3 and amyotrophic lateral sclerosis.